학술논문
Health-related quality of life maintained over time in patients with relapsed or refractory multiple myeloma treated with daratumumab in combination with bortezomib and dexamethasone: results from the phase III CASTOR trial
Document Type
Article
Author
Source
In: British Journal of Haematology . (British Journal of Haematology, May 2021, 193(3):561-569)
Subject
Language
English
ISSN
13652141
00071048
00071048